• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRAF突变的异质性分布支持多灶性乳头状甲状腺癌中不同肿瘤灶的独立克隆起源。

The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma.

作者信息

Giannini Riccardo, Ugolini Clara, Lupi Cristiana, Proietti Agnese, Elisei Rossella, Salvatore Giuliana, Berti Piero, Materazzi Gabriele, Miccoli Paolo, Santoro Massimo, Basolo Fulvio

机构信息

Departments of Surgery, University of Pisa, 56126 Pisa, Italy.

出版信息

J Clin Endocrinol Metab. 2007 Sep;92(9):3511-6. doi: 10.1210/jc.2007-0594. Epub 2007 May 29.

DOI:10.1210/jc.2007-0594
PMID:17535994
Abstract

CONTEXT

Papillary thyroid carcinoma (PTC) is frequently multifocal. Independent PTC foci may occur either from intraglandular metastases from a single dominant tumor or as unrelated neoplastic clones. In rare cases, the simultaneous presence of PTC foci of different histopathological subtypes points to independent sites of tumor formation.

OBJECTIVES

We examined the pattern of BRAF mutations in noncontiguous tumor foci and node metastases from 69 patients affected by multicentric PTC. These included 19 cases characterized by the simultaneous presence of different PTC histopathological variants.

DESIGN

BRAF (exon 15) mutation was examined by PCR-single strand conformational polymorphism followed by DNA sequencing in laser-capture microdissected tissue samples.

RESULTS

Discordant patterns of BRAF mutation were found in about 40% of the multifocal PTCs. In node metastases, BRAF mutations were, in most but not all the cases, concordant with the dominant tumor. A discordant pattern of BRAF mutation was also found in about 50% of the cases in which multiple foci of different histopathological variants were present.

CONCLUSIONS

The heterogeneous distribution of BRAF mutations suggests that discrete tumor foci in multifocal PTC may occur as independent tumors. This information has to be considered in the design of targeted therapeutic approaches with BRAF pathway inhibitors.

摘要

背景

甲状腺乳头状癌(PTC)常为多灶性。独立的PTC病灶可能源于单个优势肿瘤的腺内转移,也可能是不相关的肿瘤克隆。在罕见情况下,不同组织病理学亚型的PTC病灶同时存在提示肿瘤形成的独立部位。

目的

我们检测了69例多中心性PTC患者非相邻肿瘤病灶和淋巴结转移灶中的BRAF突变模式。其中包括19例同时存在不同PTC组织病理学变异的病例。

设计

采用聚合酶链反应-单链构象多态性(PCR-SSCP)结合DNA测序技术,对激光捕获显微切割的组织样本进行BRAF(第15外显子)突变检测。

结果

在约40%的多灶性PTC中发现BRAF突变模式不一致。在淋巴结转移灶中,大多数(但并非所有)病例的BRAF突变与优势肿瘤一致。在约50%存在不同组织病理学变异多个病灶的病例中也发现了BRAF突变的不一致模式。

结论

BRAF突变的异质性分布提示多灶性PTC中的离散肿瘤病灶可能是独立发生的肿瘤。在设计BRAF通路抑制剂的靶向治疗方案时必须考虑这一信息。

相似文献

1
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma.BRAF突变的异质性分布支持多灶性乳头状甲状腺癌中不同肿瘤灶的独立克隆起源。
J Clin Endocrinol Metab. 2007 Sep;92(9):3511-6. doi: 10.1210/jc.2007-0594. Epub 2007 May 29.
2
Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.多灶性乳头状甲状腺癌中BRAF(V600E)突变状态的差异分析:不同肿瘤灶独立克隆起源的证据
Cancer. 2006 Oct 15;107(8):1831-8. doi: 10.1002/cncr.22218.
3
Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysis.多中心性多发性甲状腺乳头状癌——HUMARA和BRAF突变分析
Cancer Med. 2015 Aug;4(8):1272-80. doi: 10.1002/cam4.466. Epub 2015 Apr 17.
4
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.与其他基因事件相关的BRAF突变可识别侵袭性乳头状甲状腺癌的一个亚组。
Clin Endocrinol (Oxf). 2008 Apr;68(4):618-34. doi: 10.1111/j.1365-2265.2007.03077.x. Epub 2007 Dec 5.
5
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.500例连续乳头状甲状腺癌患者中BRAF V600E突变与不良临床病理结局的相关性
J Clin Endocrinol Metab. 2007 Nov;92(11):4085-90. doi: 10.1210/jc.2007-1179. Epub 2007 Sep 4.
6
Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone.大多数多灶性乳头状甲状腺癌在初始肿瘤克隆发生腺内播散后,通过亚克隆进化获得遗传和形态学多样性。
J Pathol. 2008 Jun;215(2):145-54. doi: 10.1002/path.2342.
7
Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status.传统型甲状腺乳头状癌的不同结构成分大多显示相同的BRAF状态。
Int J Cancer. 2007 Jan 1;120(1):196-200. doi: 10.1002/ijc.22290.
8
Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.多灶性乳头状甲状腺癌中不同肿瘤病灶的独立克隆起源
N Engl J Med. 2005 Jun 9;352(23):2406-12. doi: 10.1056/NEJMoa044190.
9
Molecular analysis of multifocal papillary thyroid carcinoma.多灶性乳头状甲状腺癌的分子分析
J Mol Endocrinol. 2008 Oct;41(4):195-203. doi: 10.1677/JME-08-0063. Epub 2008 Jul 15.
10
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.甲状腺乳头状癌中B-RAFV600E突变与临床病理参数的相关性:来自一项意大利多中心研究的数据及文献综述
Endocr Relat Cancer. 2006 Jun;13(2):455-64. doi: 10.1677/erc.1.01086.

引用本文的文献

1
Reappraisal of BRAFK601E-positive thyroid tumors in the NIFTP era.重新评估 NIFTP 时代 BRAFK601E 阳性甲状腺肿瘤。
Endocr Relat Cancer. 2024 Nov 22;31(12). doi: 10.1530/ERC-24-0207. Print 2024 Dec 1.
2
Multi-UniFocality (MUF), in contrast to multifocality, in thyroid lesions: Relation to lymphocytic thyroiditis.多灶性(MUF)与甲状腺病变中的多灶性不同:与淋巴细胞性甲状腺炎的关系。
Pathol Int. 2024 May;74(5):274-284. doi: 10.1111/pin.13421. Epub 2024 Apr 1.
3
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review.
甲状腺嗜酸细胞癌中的BRAF K601E突变:一例报告及文献综述
J Clin Med. 2023 Nov 7;12(22):6970. doi: 10.3390/jcm12226970.
4
PREDICTORS OF MULTIFOCAL PAPILLARY THYROID CANCER. DO THEY EXIST?多灶性乳头状甲状腺癌的预测因素。它们存在吗?
Acta Endocrinol (Buchar). 2022 Oct-Dec;18(4):424-428. doi: 10.4183/aeb.2022.424.
5
Bilateral follicular variant of papillary thyroid cancer with different RAS mutations detected with next-generation sequencing: Report of an unusual case and literature review.双侧滤泡状甲状腺癌伴不同 RAS 基因突变的下一代测序检测:不常见病例报告及文献复习。
Diagn Cytopathol. 2022 Oct;50(10):E275-E279. doi: 10.1002/dc.25004. Epub 2022 Jun 18.
6
Tissue architecture delineates field cancerization in BRAFV600E-induced tumor development.组织架构描绘了 BRAFV600E 诱导的肿瘤发展中的肿瘤异质性。
Dis Model Mech. 2022 Feb 1;15(2). doi: 10.1242/dmm.048887. Epub 2021 Aug 11.
7
Prevalence and predictor for malignancy of contralateral thyroid nodules in patients with unilateral PTMC: a systematic review and meta-analysis.单侧甲状腺微小癌患者对侧甲状腺结节的恶性患病率及预测因素:一项系统评价和荟萃分析
Endocr Connect. 2021 Jun 21;10(6):656-666. doi: 10.1530/EC-21-0164.
8
Association Between the Presence of Female-Specific Tumors and Aggressive Clinicopathological Features in Papillary Thyroid Cancer: A Retrospective Analysis of 9,822 Cases.女性特异性肿瘤与甲状腺乳头状癌侵袭性临床病理特征之间的关联:9822例病例的回顾性分析
Front Oncol. 2021 Mar 11;11:611471. doi: 10.3389/fonc.2021.611471. eCollection 2021.
9
The clinical importance of multifocality on tumor recurrence in papillary thyroid carcinoma.多灶性对甲状腺乳头状癌肿瘤复发的临床重要性。
Gland Surg. 2021 Jan;10(1):273-278. doi: 10.21037/gs-20-603.
10
An affordable immunohistochemical approach to estimate the prevalence of in large cohort studies-establishing the baseline rate of mutation in an institutional series of papillary thyroid carcinoma from Thailand.一种经济实惠的免疫组织化学方法,用于在大型队列研究中估计[具体内容缺失]的患病率——确定泰国某机构一系列甲状腺乳头状癌中[具体内容缺失]突变的基线率。
Gland Surg. 2020 Oct;9(5):1867-1877. doi: 10.21037/gs-20-388.